Pensions & Investments Logo
ETF Exchange > PJP ETF

PJP - ETF Fact Sheet

Invesco Dynamic Pharmaceuticals ETF - USD

Fund Identification

Ticker

PJP

ISIN

US46137V6627

Main Metrics

Price

$119.64

Expense Ratio

0.57%

AuM

$435.50M

Tracking Difference

-0.80%

Ratings

Trackinsight rating

N/A

Official Investment Strategy

The Invesco Dynamic Pharmaceuticals ETF (Fund) is based on the Dynamic Pharmaceutical Intellidex℠ Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

PJP's historical prices, performance, and flows

-2.00.02.04.06.08.0%
1m returns
6.24%
1m flows
$67M
* Net total returns
All data as of 17 July 2026

The ETF Exchange is brought to you by

State Street
With data and analysis by
Trackinsight
See all PJP data with a
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.

PJP's characteristics

Manager

Manager statistics

651 funds, $1,150.52Bn in AUM

Benchmark

Dynamic Pharmaceutical Intellidex Total Return Index - USD

Replication method

Direct (Physical)

Asset class

Equity

Dividend policy

Distributing
PJP's exposure

Countries

USA
94.10%

Sectors

Healthcare
100.00%

Top 5 holdings

Eli Lilly & Co.
5.45%
Corcept Therapeutics, Inc.
5.23%
Liquidia Corp.
5.15%
Merck & Co., Inc.
4.87%
Pfizer Inc.
4.85%
Total holdings
29
Total weight of top 5
25.56%
8.0%